Correlation Between Mineralys Therapeutics, and Belite Bio
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Belite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Belite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Belite Bio ADR, you can compare the effects of market volatilities on Mineralys Therapeutics, and Belite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Belite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Belite Bio.
Diversification Opportunities for Mineralys Therapeutics, and Belite Bio
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Mineralys and Belite is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Belite Bio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Belite Bio ADR and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Belite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Belite Bio ADR has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Belite Bio go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Belite Bio
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Belite Bio. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.17 times less risky than Belite Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Belite Bio ADR is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 6,779 in Belite Bio ADR on August 29, 2024 and sell it today you would lose (35.00) from holding Belite Bio ADR or give up 0.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Belite Bio ADR
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Belite Bio ADR |
Mineralys Therapeutics, and Belite Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Belite Bio
The main advantage of trading using opposite Mineralys Therapeutics, and Belite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Belite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Belite Bio will offset losses from the drop in Belite Bio's long position.| Mineralys Therapeutics, vs. Ultra Clean Holdings | Mineralys Therapeutics, vs. Playtika Holding Corp | Mineralys Therapeutics, vs. Helmerich and Payne | Mineralys Therapeutics, vs. Capital Clean Energy |
| Belite Bio vs. Anebulo Pharmaceuticals | Belite Bio vs. Mineralys Therapeutics, Common | Belite Bio vs. AN2 Therapeutics | Belite Bio vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |